A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia
Clinical trial NCT02969382 · COMPLETED
Trial details
- NCT number
- NCT02969382
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-05
- Primary completion
- 2018-07-31
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.